Search

Get tips from a Memorial Sloan Kettering dietitian if you’ve completely lost your appetite during cancer treatment.

… Thursday, October 17, 2019 Summary A Memorial Sloan Kettering expert offers strategies to help people with cancer who feel like they can’t eat anything. In the Kitchen CancerSmart: In the Kitchen with MSK Learn more Getting proper nutrition during cancer treatment is vital. As the body tries to cope

… Thursday, April 6, 2023 Memorial Sloan Kettering Cancer Center (MSK) researchers have discovered that innate immune signaling drives late cardiac toxicity after DNA-damaging cancer therapies. Their results, published in the Journal of Experimental Medicine on March 6, 2023, identify a targetable mechanism

With the power of advanced microscopes, Sloan Kettering Institutes scientists are pushing the boundaries of what can be seen and measured.

… Wednesday, May 26, 2021 VIDEO | 00:25 A Developing Mouse Embryo This movie from the Kat Hadjantonakis lab shows an 11-day-old mouse embryo with its internal organs labeled in different fluorescence. The video was prepared by postdoc Evan Bardot. Video Details If you’ve ever explored Google Earth, you

Learn how to organize your medical records once and for all.

… Friday, January 31, 2025 Summary Making the decision to sort that pile of papers on your desk is an accomplishment in and of itself. Two experts who know the ins and outs of medical records share their best tips for cataloging it all. Organizing can be onerous, but the payoffs are powerful. Less clutter

Updated survival outcomes from the EMBER-3 trial reinforced the clinical benefit of imlunestrant-based regimens as all-oral, chemotherapy-free treatment options for endocrine-pretreated patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer. Breast medical oncologist Komal Jhaveri, MD, FACP, presented the latest results for the trial at SABCS, and was also the lead and corresponding author of the paper published simultaneously in the Annals of Oncology.

… Friday, December 12, 2025 Updated survival outcomes from the EMBER-3 trial reinforced the clinical benefit of imlunestrant as monotherapy and in combination with abemaciclib as oral, chemotherapy-free treatment options for patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor

The three recipients of the 2023 Paul Marks Prize for Cancer Research will present their research at a symposium. Learn about the research of Mark Agnel Frederick Dawson, Cigall Kadoch, and Michelle Monje,

… Monday, March 18, 2024 The three recipients of the 2023  Paul Marks Prize for Cancer Research will present their research at a symposium to be held March 26, 2024. The prize was named in honor of the late  Paul A. Marks, MD , President Emeritus of Memorial Sloan Kettering Cancer Center (MSK). It recognizes

Get to know Florisela Herrejon Chavez, a cancer biology graduate student in the Gerstner Sloan Kettering School of Biomedical Sciences.

… Wednesday, March 25, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Florisela Herrejon Chavez is a graduate student in the Kharas lab  in the Sloan Kettering Institute. When and

On July 22, 2021, Memorial Sloan Kettering Cancer Center was prominently featured on NBC News/The Today Show about “How to Navigate Nation’s Top Hospitals.”

… Thursday, July 22, 2021 On July 22, 2021, Memorial Sloan Kettering Cancer Center was prominently featured on NBC News/The Today Show about “ How to Navigate Nation’s Top Hospitals .” The segment positioned MSK as a leader in cancer care while highlighting our specialized care and personal approach and

MSK joins other leading cancer institutions in calling for increased vaccination to protect against human papillomavirus, which causes many forms of cancer.

… Wednesday, January 27, 2016 Summary Vaccination rates for the human papillomavirus (HPV) vaccine remain low despite clear evidence that infection with the virus increases the risk of many forms of cancer — including cervical cancer and head and neck cancer . Today, MSK was one of 69 top cancer centers

A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC).

… Saturday, May 30, 2009 A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC). Results from the Phase III “ATLAS” trial were presented today by Dr. Vincent Miller of Memorial Sloan Kettering Cancer Center